Answers are grounded in this paper and cite their sources.
In this short-term study, MLN02 was more effective than placebo for the induction of clinical and endoscopic remission in patients with active ulcerative colitis.
No takes yet. Share an insight, caveat, or question.
Feagan et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: